AvePoint (AVPT) Could Be 45% Undervalued Following Strong Results And Higher Guidance

AvePoint (AVPT) shares are in focus after the company paired strong second quarter 2026 results with higher full year revenue guidance and highlighted growing traction in its AI governance portfolio.

See our latest analysis for AvePoint.

AvePoint’s recent revenue guidance upgrade and AI governance product launches have come alongside a strong 90 day share price return of 32.99%, although the 1 year total shareholder return is down 13.14%. This indicates that momentum has strengthened more in the short term than over longer horizons.

If AvePoint’s AI focus has your attention, it can be useful to see what else is moving in related areas and compare business models through the 30 AI small caps.

Bulls point to AvePoint’s upgraded guidance and fast growing AI governance pipeline. Bears highlight the weaker 1 year return and question how much is already priced in after the recent jump. Which side does the current valuation support?

Most Popular Narrative: 44.8% Undervalued

AvePoint’s most followed narrative points to a fair value of $23.61 per share, compared with the last close at $13.02, which sets up a wide valuation gap for investors to unpack.

Rising urgency to safely deploy AI and agentic AI across regulated industries is accelerating demand for AvePoint’s governance-first platform, supporting durable double-digit ARR growth and expanding high-margin SaaS revenue.

Read the complete narrative.

Want to see what sits behind that valuation gap? The narrative leans on sustained revenue compounding, higher margins and a premium earnings multiple that assumes AvePoint keeps winning bigger AI governance deals.

Result: Fair Value of $23.61 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, AvePoint’s reliance on Microsoft-related revenue and its exposure to large, long-cycle AI governance projects could limit upside if customer adoption or budgets disappoint.

Find out about the key risks to this AvePoint narrative.

Next Steps

The mix of cautious and optimistic signals around AvePoint makes this a good moment to review the details for yourself and act promptly. To see how the upside and downside compare in one place, review the 3 key rewards and 1 important warning sign.

Looking for more investment ideas beyond AvePoint?

If AvePoint has sharpened your focus, do not stop here. Use the Simply Wall Street Screener to quickly surface other shares that match your investing style.

• Target potential mispricings by scanning for quality companies that might trade below their estimated worth through the 49 high quality undervalued stocks.
• Prioritise resilience by filtering for companies with strong finances using the solid balance sheet and fundamentals stocks screener (49 results).
• Spot potential standouts early by reviewing the screener containing 20 high quality undiscovered gems before the crowd catches on.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com